Metagenomic next-generation sequencing assistance in identifying non-tuberculous mycobacterial infections

Abstract

IntroductionThe advent of metagenomics next-generation sequencing (mNGS) has garnered attention as a novel method for detecting pathogenic infections, including Non-Tuberculous Mycobacterial (NTM) and tuberculosis (TB).However, the robustness and specificity of mNGS in NTM diagnostics have not been fully explored.MethodsIn this retrospective study, we enrolled 27 patients with NTM genomic sequences via mNGS and conducted a comprehensive clinical evaluation.ResultsPulmonary NTM disease was the most commonly observed presentation, with a subset of patients also presenting with extrapulmonary NTM infections.mNGS analysis identified six distinct NTM species, primarily Mycobacteriumavium complex (MAC), followed by Mycobacterium intracellulare andMycobacterium abscessus. Conventional routine culture methods encountered challenges, resulting in negative results for all available 22 samples. Among the 10 patients who underwent quantitative polymerase chain reaction (qPCR) testing, five tested positive for NTM.DiscussionIt is important to note that further species typing is necessary to determine the specific NTM type, as traditional pathogen detection methods serve as an initial step. In contrast, when supplemented with pathogen data, enables the identification of specific species, facilitating precise treatment decisions. In conclusion, mNGS demonstrates significant potential in aidingthe diagnosis of NTMdisease by rapidly detecting NTM pathogens and guiding treatment strategies. Its enhanced performance, faster turnaround time (TAT), and species identification capabilities make mNGS a promising tool for managing NTM infections.

Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of Nocardia pneumonia: a case report

“…Compared to culture-based methods requiring an average feedback time of 7–14 days, mNGS provides pathogenic evidence within 2–3 days ( 21 ). Its ability to directly type pathogens without the need for further strain identification enables immediate initiation of targeted treatment based on the type of pathogen identified ( 24 ). As a result of this characteristic of mNGS more precise clinical use of drugs can be achieved and pathogen treatment can be optimized ( 25 ).…”

Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification

“…While circumventing the limitations and biases inherent to traditional culturing methods, it’s important to acknowledge scenarios where traditional methods may still offer valuable insights, particularly in understanding microbial growth characteristics and antibiotic susceptibility. mNGS facilitates the detection of microbial nucleic acids across a variety of specimen types and enables rapid identification of multiple pathogens, with numerous cases of NTM infections being diagnosed through this method ( 50 , 52 , 53 ).…”

Unveiling the Clinical Diversity in Nontuberculous Mycobacteria (NTM) Infections: A Comprehensive Review

“…These technologies enable rapid and comprehensive analysis of NTM infections, providing invaluable information for diagnosis and epidemiological studies. NGS can help detect NTM species even when conventional methods fail to do so, and metagenomics can offer a broader understanding of the microbial communities within complex clinical samples [ 81 ].…”